KD Logo

Harvard Bioscience Inc. [NASDAQ: HBIO] Sees Decrease in Stock Value

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Harvard Bioscience Inc. shares valued at $29,100 were purchased by Green James W on Jun 13 ’24. At $2.91 per share, Green James W acquired 10,000 shares. The insider’s holdings grew to 3,111,091 shares worth approximately $8.62 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Green James W purchased 20,000 shares, netting a total of over 61,400 in proceeds. Following the buying of shares at $3.07 each, the insider now holds 3,101,091 shares.

Before that, Green James W had added 25,000 shares to its account. In a trade valued at $109,500, the Chief Executive Officer bought Harvard Bioscience Inc. shares for $4.38 each. Upon closing the transaction, the insider’s holdings increased to 25,000 shares, worth approximately $7.93 million.

As published in a research note from The Benchmark Company on March 10, 2023, Harvard Bioscience Inc. [HBIO] has been rated up from a Speculative buy to a Buy and the price target has been revised to $4 from $3. Analysts at The Benchmark Company upgraded the stock from ‘”a Speculative buy”‘ to ‘”a Buy”‘ outlook in a report released in early January. As of December 09, 2020, Northland Capital has initiated its “an Outperform” rating for HBIO. Earlier on November 10, 2020, KeyBanc Capital Markets initiated its rating. Their recommendation was “an Overweight” for HBIO stock.

Analyzing HBIO Stock Performance

During the last five days, there has been a drop of approximately -4.15%. Over the course of the year, Harvard Bioscience Inc. shares have dropped approximately -48.22%. Shares of the company reached a 52-week high of $5.43 on 01/02/24 and a 52-week low of $2.75 on 07/03/24. A 50-day SMA is recorded $3.24, while a 200-day SMA reached $4.15. Nevertheless, trading volume fell to 56343.0 shares from 0.16 million shares the previous day.

Support And Resistance Levels for Harvard Bioscience Inc. (HBIO)

According to the 24-hour chart, there is a support level at 2.73, which, if violated, would cause prices to drop to 2.70. In the upper region, resistance lies at 2.82. The next price resistance is at 2.88. RSI (Relative Strength Index) is 32.90 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.08, which suggests the price will decrease in the coming days. Percent R is at 92.73%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.

Most Popular